Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04068844 · ClinicalTrials.gov registry record · NA

Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction

A NA study of Heart Failure, Diastolic, sponsored by University of Texas Southwestern Medical Center.

Active
Registry status
NA
Development phase
93
Enrollment target
1
Study location

NCT04068844 is a NA study of Heart Failure, Diastolic that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 93 participants, below the 314-participant average among 14 other Heart Failure, Diastolic trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04068844, a NA study of Heart Failure, Diastolic, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
93 participants
Enrollment target
1
Study location

Study Summary

The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise training

Study Locations (1)

Texas

  • The Institute for Exercise and Environmental Medicine - Dallas

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2019-08-01
Est. Completion 2025-12-31
Phase NA

What the Registry Record Tells You About NCT04068844

The ClinicalTrials.gov registry entry for NCT04068844 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 314-participant average among 14 other Heart Failure, Diastolic trials with a reported enrollment target (70% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure, Diastolic appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.

NCT04068844 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04068844 about?

NCT04068844 is a clinical study titled "Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction". The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.

What is the current status of trial NCT04068844?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 93 participants. The study started on 2019-08-01. Estimated completion is 2025-12-31.

What conditions does trial NCT04068844 study?

This clinical trial studies the following conditions: Heart Failure, Diastolic.

What interventions are being tested in trial NCT04068844?

The interventions under investigation include: Exercise training (BEHAVIORAL).

Who is sponsoring clinical trial NCT04068844?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04068844 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure, Diastolic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.